Article Archives >> Technology
We are on the brink of a budding new technology trend that is of the same scale—possibly bigger—as email and the internet.
It’s not a stock market crash, economic depression, or even a global currency crisis.
If this market isn’t on your radar yet, it should be.
If you’ve ever thought about investing in a biotech stock, make sure you print out this essay.
Here's how you can protect yourself (and profit) from desperate governments...
And we've barely scratched the surface of what it can do...
It will be prolific, pervasive, and profound for society. And the market could be as big as $120 billion by 2020...
For better or worse, the era of ubiquitous persuasive technology has arrived… and it isn’t going anywhere.
Nootropics may turbocharge your brain, but for now, they won’t turbocharge your investment portfolio
Can all that energy from water flowing through municipal pipes be harnessed? One company says yes.
In the brave new crowdfunding world, you can be not just a backer, but an investor.
Apple’s high–end watch isn’t going to boost the price of gold
The technology of synthetic biology company Amyris is easy to fall in love with, but are current investors blinded to problems with the business?
Elon Musk might be crazy. Or he might be a genius. Either way, utilities are in trouble.
The latest and greatest from Barcelona.
Why we need better batteries; Pebble launches another successful Kickstarter campaign; and Lenovo backtracks on Superfish
Coming your way: $4,000 Apple watches and genetically modified apples?
Net Neutrality appears to have the upper hand again; and why cyberthieves are hot for healthcare data
News from several tech companies has investors’ attention
What’s the deeper story behind Apple’s latest earnings results?
Is there a way for investors to ride the trend of medical marijuana?
HealthCare.gov is a data sieve; and the likelihood of drone wars in the near future just crept a little higher
This year’s Consumer Electronics Show featured a lot of IoT and monitoring tech, but not the one thing consumers report wanting most
Our latest tech news roundup, including a peek at the Consumer Electronics Show
Apple Pay flops, 3D printing stocks drop, Solar plops, but Microsoft’s new OS tops…
Big banks are out of ideas; Tesla gets sludged by oil; and North Korea can’t take a joke
Online dating is heating up. And unfortunately, so are the cyberwars.
Are you concerned that your coffee cup may be spying on you? Turns out it's not as far-fetched an idea as you might think.
Can Tesla maintain its lead in the electric car market over the big car companies? And is Uber trying to test the limits on the old saying that there's no such thing as bad publicity?
Amazon still appears to have its fingers firmly on the pulse of tech-savvy shoppers, so why is there a call to short the company? Plus loads of other interesting tech bits and bytes
Apple Pay launches with a thud; Darknet commerce is booming; and Tim Cook distracts the media.
Intercellular communication is revealing new ways to approach infection… and cancer
HP has a shot at creating a great computing breakthrough... if the company doesn’t muff it as it has previous opportunities
Why Icahn’s Apple share repurchase argument has merit
This obvious aspect of tech design can be overlooked by engineers… and can tank the company
Can you protect your digital data from the ever-encroaching government?
Biotechnology is opening up amazing possibilities in biobased products
A look at the role venture capital plays in the formation of bubbles, and speculating on an Apple Watch-based boost
Flexible electronic technology is here, and it’s going to rock your world.
In today's techstravaganza, an update on anti-aging science, and the third chapter in our tech bubble series
All the crazy M&A activity in tech must indicate we’re floating in a new bubble. Or does it? What do the numbers really say?
Google’s desperation and an overbought Nasdaq: is this the dot-com bubble all over again?
The computing giant may still have a trick or two up its sleeve
How low can cloud storage prices go?
Learn how some game-changing technologies were inspired by nature
Could viruses hold the key to safely killing cancer cells?
If you’re a nimble, savvy investor, there’s opportunity for profit in the PC space
One simple and basic step can save a lot of investment worries… Do you take it?
Robotic-assisted surgery is on the cusp of a breakthrough… and poised to offer savvy investors outsized profits
Revealed—the facts behind the high-frequency trader scaremongering
The successor to compact fluorescent light bulbs is on the horizon… and close enough for investors to profit from the right company
Snowden a traitor? Famed venture capitalist sticks foot in mouth.
Stem cell science is on the cusp of producing the kinds of results that get biotech investors excited
A new trend is making its way into the mainstream—how to catch it, how to play it
The African economic boom is for real, and we’ve found a way to profit.
This company works on a treatment for wet age-related macular degeneration—and some all-important trial results are due out soon…
Digging into the promising veneer of buying a taxi medallion reveals some intriguing parallels to a little-known but growing investment sector
How developing orphan drugs became a 50-billion-dollar market
Drugs taking advantage of the CRISPR-Cas system could eventually replace all antibiotics.
Synthetic biology is becoming cheaper and easier… and pretty darned clever
Having an information advantage can help a retail investor beat even the high-frequency traders
WISP appears to be the best way to get Internet access to the last mile… wherever it may be
Human-organs-on-chips are poised to revolutionize medical and drug testing
Alex Daley meets an untimely demise.
The smart grid is on its way at long last
Why the antibacterial war must end
If you have bitcoins, here’s how to keep them as safe as possible
How a new treatment for Alzheimer’s could change the medical landscape forever… and make fortunes for early investors
The ENCODE Project appears to be on the cusp of delivering breakthrough genetic treatments
Epigenetics is already offering a lot of promise in unraveling the mysteries of how genes work, how the environment can influence them, and how tech can counter or correct problems that lead to ill health.
Why Andreessen's famed bitcoin commentary is wide of the mark
Technology is starting to untangle the delicate question of our sexual nature, by peering into the human genome.
A primer in making successful contrarian plays in the tech sector
A brief overview of this year's Consumer Electronics Show reveals why our tech team is jonesing to attend next year's techstravaganza—and you can help one of them get there.
An ingenious tech could make brownouts and rolling blackouts obsolete
Pros and cons of today's technology.
How to play tech stocks in 2014 for maximum gains
Exactly how far-fetched is the idea of using drones for delivery services… or other nonmilitary uses?
The FDA's stance on genomic testing is hypocritical and insulting to consumers.
Despite all the hype about Bitcoin's dubious legality, the US government would be stupid to shut it down
Discussion of another dot-com bubble brewing is mostly overblown… mostly.
Systems security is more precarious than most of us—even the tech savvy among us—realize
The one all-important factor all your biotech investments should have
Most investors know how to minimize political risk. Are you among those savvy enough to profit from it… in all its possible forms?
Automation is the key to the next phase of China's economic growth.
Biohacking is shaking up the worlds of science, technology, and politics.
Anticancer vaccines are making slow but steady progress.
And it's getting stronger and less expensive
The new face of agriculture: precision farming.
Even the government is getting in on the hacking—and the courts are allowing them to do it.
One small company is cleaning up from Google's Android mess.
One investment available to all that earns twice as much.
Traditional businesses continue to be disrupted by tech advances.
Far more than PRISM
Weapons of mass disruption are growing ever more exotic.
Software is making human beings obsolete.
Why investors should care about biotech venture capital.
Niche diseases could bring windfall profits to Big Pharma… but not in the way you might think.
Creating a kinder, gentler needle.
Revealed: free and cheap technologies to help keep government snoops from spying on you.